In fact, the two types of errors are natural in any statistical testing procedure. In any testing procedure, the validity/correctness of some hypothesis of prior belief is to be judged on the basis of data. This prior belief is called the “null hypothesis”, and is considered to be true unless and until there is strong data-based reason to think otherwise. A “type I error” is rejecting the null hypothesis incorrectly, and a “type II error” is failing to reject a null hypothesis. One is seeing an effect when there isn’t one (e.g., diagnosis of a serious disease when it is not there), and the other is missing an effect (e.g., missing to diagnosing a disease when it is present). Both are serious. However, it is delicate to decide which one is more serious. In many cases, type II errors are considered to be more serious than type I errors. The objective of a clinical experiment, or any statistical testing in general, is to minimise these errors. However, unfortunately, it is impossible to minimise both the errors simultaneously. For example, if one intends to reduce type II error, the testing procedure should be made sensitive to tiny indicators of the onset of disease. And that, in effect, would invariably enhance the type I error. On the other hand, in order to reduce the type I error, one needs to ignore minor indications of the onset of disease — only strong indication of disease would be considered, and that will automatically lead to missing some genuine cases of disease onset, resulting in the increase of type II error. Usually, most of the testing procedures are such that there are some pre-assigned type I error rate (say 5 per cent), and also some prefixed type II error rate (say 5 per cent, or 10 per cent, or 20 per cent), depending on the situation. But, remember that a 5 per cent type I error implies that 1 in 20 individuals without a disease would be diagnosed to be having a disease, and a 10 per cent type II error indicates that the procedure would miss finding the disease of 1 in 10 patients having the disease. That’s a huge margin.